| Dr Johanna Gabriela Finkle, MD | |
|
3901 Rainbow Blvd, Kansas City, KS 66160-8500 | |
| (913) 588-6200 | |
| (913) 588-6271 |
| Full Name | Dr Johanna Gabriela Finkle |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750505988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2011023170 (Missouri) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 04-35205 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration.
The influenza virus remains a worldwide threat to humans, causing an average of 36,000 deaths and 200,000 hospitalizations each year in the United States alone. As health care professionals prepare for another flu season, a University of Missouri scientist is studying how two enzymes could be used to stop the virus in its tracks.
Dyax Corp. today announced financial results for the second quarter ended June 30, 2012.
› Verified 9 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration.
The influenza virus remains a worldwide threat to humans, causing an average of 36,000 deaths and 200,000 hospitalizations each year in the United States alone. As health care professionals prepare for another flu season, a University of Missouri scientist is studying how two enzymes could be used to stop the virus in its tracks.
Dyax Corp. today announced financial results for the second quarter ended June 30, 2012.
› Verified 9 days ago
| Entity Name | Rockhill Women's Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336181734 PECOS PAC ID: 4082628219 Enrollment ID: O20170209000518 |
News Archive
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration.
The influenza virus remains a worldwide threat to humans, causing an average of 36,000 deaths and 200,000 hospitalizations each year in the United States alone. As health care professionals prepare for another flu season, a University of Missouri scientist is studying how two enzymes could be used to stop the virus in its tracks.
Dyax Corp. today announced financial results for the second quarter ended June 30, 2012.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Johanna Gabriela Finkle, MD 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-6200 | Dr Johanna Gabriela Finkle, MD 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-6200 |
News Archive
A Mount Sinai Medical Center study has found that lower frequency deep brain stimulation in young patients with primary torsion dystonia is as effective as higher frequency stimulation, which has been commonly used.
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration.
The influenza virus remains a worldwide threat to humans, causing an average of 36,000 deaths and 200,000 hospitalizations each year in the United States alone. As health care professionals prepare for another flu season, a University of Missouri scientist is studying how two enzymes could be used to stop the virus in its tracks.
Dyax Corp. today announced financial results for the second quarter ended June 30, 2012.
› Verified 9 days ago
Dr. Madhuri G Reddy, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Obgyn Dept, Ms 2028, Kansas City, KS 66160 Phone: 913-588-6257 Fax: 913-588-6271 | |
Dr. Marc Ronald Parrish, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 2028, Kansas City, KS 66160 Phone: 913-588-6201 Fax: 913-588-6271 | |
Megan Eileen Madrigal, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mailstop 2028, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6218 | |
Gene T. Lee, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: University Of Kansas Medical Center, 3901 Rainbow Blvd., Ms2028, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6271 | |
Dr. Annabel Mancillas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6271 | |
Dr. Charles W Gibbs, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mailstop 2028, Kansas City, KS 66160 Phone: 913-588-6201 Fax: 913-588-6271 | |
Lindsay R Nordwald, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Ku Women's Health Specialty Centers, 3901 Rainbow Blvd., Ms 2028, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6271 |